INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 278 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $20,113,593 | +9.4% | 493,222 | 0.0% | 0.34% | +0.9% |
| Q1 2023 | $18,382,384 | +65.2% | 493,222 | +54.6% | 0.34% | +53.9% |
| Q4 2022 | $11,129,910 | -37.7% | 319,000 | 0.0% | 0.22% | -37.6% |
| Q3 2022 | $17,851,000 | -41.1% | 319,000 | -42.1% | 0.35% | -24.5% |
| Q4 2020 | $30,327,000 | – | 551,400 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $22,900,458 | 11.62% |
| Casdin Capital, LLC | 1,275,000 | $51,994,500 | 4.54% |
| BioImpact Capital LLC | 544,639 | $22,210,378 | 4.47% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $46,696,811 | 4.26% |
| ARK Investment Management | 9,525,931 | $388,467,484 | 2.57% |
| Merlin Capital LLC | 17,641 | $719,400 | 2.44% |
| Atlas Venture Associates IX, LLC | 10,000 | $407,800 | 2.23% |
| Orchard Capital Management, LLC | 310,958 | $6,490,341 | 2.18% |
| Deep Track Capital, LP | 835,446 | $34,069,488 | 1.58% |
| Nikko Asset Management Americas, Inc. | 3,394,656 | $138,298,285 | 1.46% |